American College of Allergy, Asthma & Immunology (ACAAI) 2020 Annual Scientific Meeting - Virtual Experience

13 November 2020 - 15 November 2020

Asian parents greatly affected by food allergies in their children

Food allergy in children affects QoL in Asian parents

Roshini Claire Anthony, 20201230180001

In Asian families, food allergies in children may affect quality of life (QoL) of their parents, according to a retrospective study from the US presented at ACAAI 2020.

Telemedicine strategy effective for asthma control in children

Roshini Claire Anthony, 20201217190100

Switching to a telemedicine-only strategy from face-to-face visits does not affect asthma control in children. Moreover, the strategy may actually increase show rates, according to a study presented at the recent ACAAI 2020 meeting.

Antihistamine/decongestant combo tablet trumps nasal spray in rapid relief of rhinitis

Pearl Toh, 20201217150000

A single dose of loratadine/pseudoephedrine combination tablet provides over twice as much nasal relief within an hour compared with fluticasone nasal spray in patients with allergic rhinitis, according to a head-to-head comparison study presented at ACAAI 2020 Meeting.

Having asthma or allergy does not increase risk for severe COVID-19

Elvira Manzano, 20201212113000

Having asthma or allergy does not make COVID-19 severe, a new study presented at ACAAI 2020 has shown.

Omalizumab shows sustained benefits in chronic rhinosinusitis with polyps

Omalizumab shows sustained benefits in chronic sinusitis with polyps

Pearl Toh, 20201210150000

The benefits of omalizumab in symptom improvements continue to hold up over 52 weeks in patients with chronic rhinosinusitis with nasal polyps (CRSwNP), according to data from the extension phase of POLYP1 and POLYP2 studies presented at the ACAAI 2020 Meeting.

Mavrilimumab improves outcomes in COVID-19 pneumonia with hyperinflammation

Audrey Abella, 03 Aug 2020

Adding the anti-GM-CSF* receptor-α monoclonal antibody mavrilimumab to standard care (SC) improved clinical outcomes in patients with severe coronavirus disease 2019 (COVID-19) pneumonia and systemic hyperinflammation who were not under mechanical ventilation (MV), an Italian study has shown.

Oral as good as IV antibiotics for ridding P aeruginosa in cystic fibrosis

Pearl Toh, 08 Dec 2020

Intravenous (IV) antibiotics are no better than oral antibiotics when it comes to eradicating Pseudomonas (P.) aeruginosa in children and adults with cystic fibrosis, yet are more costly than the latter, reveals the TORPEDO-CF study.